0001127602-23-012944.txt : 20230417
0001127602-23-012944.hdr.sgml : 20230417
20230417070103
ACCESSION NUMBER: 0001127602-23-012944
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230413
FILED AS OF DATE: 20230417
DATE AS OF CHANGE: 20230417
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Luput Cristian
CENTRAL INDEX KEY: 0001913350
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41455
FILM NUMBER: 23822797
MAIL ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MAIA Biotechnology, Inc.
CENTRAL INDEX KEY: 0001878313
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
BUSINESS PHONE: 312-416-8592
MAIL ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
4
1
form4.xml
PRIMARY DOCUMENT
X0407
4
2023-04-13
0001878313
MAIA Biotechnology, Inc.
MAIA
0001913350
Luput Cristian
444 WEST LAKE STREET, SUITE 1700
CHICAGO
IL
60606
1
1
Common Stock
2023-04-13
4
P
0
622
3.62
A
292690
D
Common Stock
2023-04-14
4
P
0
802
3.58
A
293492
D
The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of Mr. Luput that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended.
The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.57 to $3.70, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.55 to $3.65, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
/s/ Cristian Luput
2023-04-17